Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

84.46
Delayed Data
As of 4:02pm ET
 +0.66 / +0.79%
Today’s Change
69.01
Today|||52-Week Range
86.90
+15.95%
Year-to-Date
Juno Reports Additional Data on CAR-T Therapy, Shares Drop
6:30pm / Zacks.com - Paid Partner Content
Puma (PBYI) Stock Up More than 200% This Year: Here's Why
Dec 08 / Zacks.com - Paid Partner Content
Regeneron's sBLA for Eylea Accepted by FDA, Action Date Set
6:30pm / Zacks.com - Paid Partner Content
Gilead Sciences to Acquire Cell Design Labs for $567 Million
Dec 08 / Zacks.com - Paid Partner Content
Novartis Announces Positive Data on Sickle Cell Disease Drug
6:20pm / Zacks.com - Paid Partner Content
Pfizer Reports Updated Data from Phase III Study on Ibrance
Dec 07 / Zacks.com - Paid Partner Content
Gilead (GILD) Posts Updated Data on CAR-T Therapy Yescarta
Dec 11 / Zacks.com - Paid Partner Content
Mylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest
Dec 04 / Zacks.com - Paid Partner Content
Novartis Reports Updated Results from Kymriah's JULIET Study
Dec 11 / Zacks.com - Paid Partner Content
Lilly's (LLY) Taltz Gets Approval for Label Expansion in US
Dec 04 / Zacks.com - Paid Partner Content
Here's Why Bluebird Bio (BLUE) Stock Skyrocketed Today
Dec 11 / Zacks.com - Paid Partner Content
5 Biotech and Pharma Stocks with FDA Catalysts this December
Nov 30 / Zacks.com - Paid Partner Content
Incyte (INCY) Reports Phase III Follow-Up Data for Jakafi
Dec 11 / Zacks.com - Paid Partner Content
How Will U.S. Tax Reform Impact Pharma/Biotech Industry?
Nov 29 / Zacks.com - Paid Partner Content
Why Thousands Will Attend ASH Hematology Conference in Atlanta This Weekend
Dec 08 / TheStreet.com - Paid Partner Content